1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the quarter ended March 31, 2026, none of our directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K).
−Removed: First Amendment to Credit Agreement, dated January 5, 2026, among Myriad Genetics, Inc., the lenders party thereto and Orbimed Royalty & Credit Opportunities IV, LP, as administrative agent (incorporated by reference to Exhibit 10.26 to the Company's Annual Report on Form 10-K, File No.
−Removed: 000-26642, filed with the SEC on February 24, 2026).
+Added: During the quarter ended June 30, 2026, none of our directors or executive officers adopted , modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K).
+Added: 10.1 Amended and Restated 2012 Employee Stock Purchase Plan, as amended (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, File No.
+Added: 000-26642, filed with the SEC on June 4 , 202 6 ) +
+Added: 10.2 2026 Employee, Director and Consultant Equity Incentive Plan (incorporated by reference to Exhibit 10.
+Added: 2 to the Company's Current Report on Form 8-K, File No.
+Added: 000-26642, filed with the SEC on June 4, 202 6 ) +
+Added: 10.3 F orm of Restricted Stock Unit Agreement under the 2026 Employee, Director and Consultant Equity Incentive Plan (Director) (incorporated by reference to Exhibit 99.2 to the Company's Registration Statement on Form S-8, Registration No.
+Added: 333-296486, filed with the SEC on June 4, 2026).
+Added: 10.4 Form of Restricted Stock Unit Agreement under the 2026 Employee, Director and Consultant Equity Incentive Plan ( Employee ) (incorporated by reference to Exhibit 99.
+Added: 3 to the Company's Registration Statement on form S-8, Registration No.
+Added: 333-296486, filed with the SEC on June 4, 2026) .+
+Added: 10.5 N on-Employee Director Compensation Policy (effective June 2026) .
31.1 Certification of Principal Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.
7 unchanged sentences
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: 104 The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 has been formatted in Inline XBRL.
+Added: 104 The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 has been formatted in Inline XBRL.
+Added: (+) Management contract or compensatory plan arrangement
* The Certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Myriad Genetics, Inc.
2 unchanged sentences
MYRIAD GENETICS, INC.
−Removed: May 6, 2026 By:
+Added: July 31, 2026 By:
/s/ Samraat S.
1 unchanged sentence
(Principal executive officer)
−Removed: May 6, 2026 By:
+Added: July 31, 2026 By:
/s/ Benjamin R.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.